Trial · NCT00232180
Adverse events3,490
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 3,490
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Atrial fibrillation | Cardiac disorders | Eplerenone: Double-blind Phase (May 25, 2010 Data Cut-off) | 29 | 1,360 | |
| other | Atrial fibrillation | Cardiac disorders | Placebo: Double-blind Phase(May 25, 2010 Data Cutoff) | 36 | 1,369 | |
| other | Atrial fibrillation | Cardiac disorders | Eplerenone: Double-blind Phase | 37 | 1,364 | |
| other | Atrial fibrillation | Cardiac disorders | Placebo: Double-blind Phase | 42 | 1,372 | |
| other | Atrial fibrillation | Cardiac disorders | Eplerenone: Open Label Phase | 42 | 1,245 | |
| other | Cardiac failure | Cardiac disorders | Eplerenone: Double-blind Phase (May 25, 2010 Data Cut-off) | 69 | 1,360 | |
| other | Cardiac failure | Cardiac disorders | Placebo: Double-blind Phase(May 25, 2010 Data Cutoff) | 99 | 1,369 | |
| other | Cardiac failure | Cardiac disorders | Eplerenone: Double-blind Phase | 84 | 1,364 | |
| other | Cardiac failure | Cardiac disorders | Placebo: Double-blind Phase | 107 | 1,372 | |
| other | Cardiac failure | Cardiac disorders | Eplerenone: Open Label Phase | 29 | 1,245 | |
| other | Constipation | Gastrointestinal disorders | Eplerenone: Double-blind Phase (May 25, 2010 Data Cut-off) | 27 | 1,360 | |
| other | Constipation | Gastrointestinal disorders | Placebo: Double-blind Phase(May 25, 2010 Data Cutoff) | 13 | 1,369 | |
| other | Constipation | Gastrointestinal disorders | Eplerenone: Double-blind Phase | 30 | 1,364 | |
| other | Constipation | Gastrointestinal disorders | Placebo: Double-blind Phase | 15 | 1,372 | |
| other | Constipation | Gastrointestinal disorders | Eplerenone: Open Label Phase | 0 | 1,245 | |
| other | Diarrhoea | Gastrointestinal disorders | Eplerenone: Double-blind Phase (May 25, 2010 Data Cut-off) | 30 | 1,360 | |
| other | Diarrhoea | Gastrointestinal disorders | Placebo: Double-blind Phase(May 25, 2010 Data Cutoff) | 40 | 1,369 | |
| other | Diarrhoea | Gastrointestinal disorders | Eplerenone: Double-blind Phase | 35 | 1,364 | |
| other | Diarrhoea | Gastrointestinal disorders | Placebo: Double-blind Phase | 46 | 1,372 | |
| other | Diarrhoea | Gastrointestinal disorders | Eplerenone: Open Label Phase | 0 | 1,245 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00232180/events